Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 2 of 20
MyPEEPS LITE Trial
NCT06741631
Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy
NCT06720545
P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American/Black Gay, Bisexual, and Same-gender Loving Men
NCT06785376
The CardioClip Study
NCT06241430
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
NCT06601933
Assessing the Maternal Outcome Monitoring Systems
NCT06415942
Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery
NCT06701422
Impella Reverse Remodeling in End-Stage Heart Failure
NCT06800716
Free Time For Wellness 2+
NCT06654843
Diazoxide Suppression Test P&F Study
NCT06606327
Gluten Technology and Education for Celiac Health
NCT06059716
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
NCT06655376
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
NCT06472206
Graded Insulin Suppression Test P&F
NCT06592261
SDOH-Homecare Intervention Focus Team (SHIFT) Trial to Improve Stroke Outcomes
NCT06397937
Low and High Flow Suctioning in Intubated Infants
NCT06443970
Medically Tailored Meals for Cardiovascular Health
NCT06550297
Early Age-Related Hearing Loss Investigation (EARHLI)
NCT06174038
Prediction of Anxiety and Memory State
NCT06551090
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
NCT06518668
Mechanistic Effect of Walnut Consumption on Sleep Quality
NCT06430086
Cognitive Control Targets for the Treatment of Obsessive Compulsive Disorder in Young Children
NCT06102941
Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
NCT05655325
Long-Covid-19 Alleviation Through Learning Mindfulness Study
NCT07140094
Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
NCT06839469
Patient Perspectives Medicaid Title XIX Sterilization Consent Form
NCT06447233
Human Models of Selective Insulin Resistance: Alpelisib, Part I
NCT06354088
Effectiveness of Motivation Skills Training (MST)
NCT05805397
Mindfulness-Based fMRI Neurofeedback for Depression
NCT05617495
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
NCT05963971
The DREAM Study: A Multidimensional Sleep Health Intervention for Improving Cardiometabolic Health
NCT06285968
Physiological Effects of Continuous Negative External Pressure for Acute Hypoxemic Respiratory Failure
NCT05675345
Gadopiclenol in Contrast Enhanced MRI of the Prostate
NCT06226129
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
NCT06108206
Kids With Iron Deficiency and Scoliosis
NCT06042699
Impact of Yo-Yo Sleep on Cardiometabolic Health
NCT05880758
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
NCT06034405
European Prospective Investigation Into Childhood Cancer
NCT05375617
Evaluation of Brain MRI Changes in Cerebral Palsy Patients
NCT07433647
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
NCT05919797
FUS Etoposide for DMG
NCT05762419
Adaptive Radiation in Anal Cancer
NCT05838391
taVNS for Persistent Symptoms From Lyme Disease
NCT05776251
Efficacy of Suvorexant on Post-operative Sleep Disturbance
NCT05823844
Effects of GH and Lirglutide on AgRP
NCT05681299
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
NCT05174286
IMPACT Trial: Intervention to iMProve AdherenCe Equitably
NCT05496829
WiseApp for Spanish Speakers Living With HIV
NCT05398185
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
NCT05341726
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
NCT05929976
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Columbia University pipeline card: 958 registered trials from official public datasets.Report a data error.